UCLA is one of the leading research institutions in the world and receives more than $1 billion in extramural research funding every year, making it the nation’s 9th largest research university. Our division benefits from this rich research environment, allowing us to contribute to cutting-edge bench, translational and clinical research to improve child health.
Our three research faculty lead cutting-edge research programs, currently funded by five R-equivalent grants from the National Institutes of Health.
Steven Mittelman's lab studies the links between obesity and poor outcome of childhood leukemia. Read more
Maureen Su's Lab examines how autoimmunity can affect endocrine function. Read more
Xingxing Kong’s lab studies how muscle and fat tissue communicate, which can both promote and prevent obesity. Read more
Our division also supports several clinical research studies, giving our patients access to cutting edge diagnostic and treatment modalities.
The Endocrine Division participates in a number of clinical research studies aimed at improving the lives of children. Some of these include:
- TrialNet - an international network dedicated to the prevention of type 1 diabetes
- IDEAL - a diet and activity intervention aimed at improving outcomes in patients with leukemia
- An Addiction Model Based Mobile Health Weight Loss Intervention
- A Pharmacokinetic Study of the Adipocyte Microenvironment on Daunorubicin Metabolism
Faculty and trainees benefit from the outstanding research environment at UCLA. See below for just a few of the programs and initiatives which impact our division:
- UCLA Children's Discovery and Innovation Institute (CDI)
- DGSOM Research Themes
- Metabolism Theme
- Immunology, Inflammation, Infection and Transplantation Theme (I3T)
- UCLA Clinical and Translational Science Institute (CTSI)
- UCLA Star Program
- Molecular Cellular Integrative Physiology (MCIP)
- Microbiology, Immunology & Molecular Genetics (MIMG)